sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Let op!
Mogelijk ziet u niet alle beschikbare info op deze pagina, omdat u niet bent ingelogd, of omdat u niet de juiste privileges heeft.

Clinical picture: NHL (Non Hodgkin Lymphoma)

Trial: HOVON-associated GO27878 study (Cavalli study)


News
1. Overview
Study details
2. Patient eligibility criteria
3. Registration (& randomization) of patients
4. Participating parties
5. Participating sites
6. Instruction videos
7. Download documentation / forms


return to top

News


The Cavalli study has been closed as of 08-02-2017


1. Overview



Summary

A phase IB/II, open-label study evaluating the safety and pharmacokinetics of GDC-0199 (ABT-199) in combination with rituximab (R) or Obinutuzumab (G) plus cyclofosfamide, doxorubicin, vincristine and prednisone (CHOP) in patients with B-cell Non-Hodgkin’s lymphoma (NHL) and DLBCL
Dose escalation part (fase Ib deel)


Status

closed


Members

Open in:
VUMC (M. Chamuleau)
UMCU (M.C. Minnema )
ErasmusMC (soon) (P.Lugtenburg).


Study details



Type of study

Prospective Phase I/II study


2. Patient eligibility criteria



3. Registration (& randomization) of patients



4. Participating parties



5. Participating sites



6. Instruction videos



7. Download documentation / forms




return to top